CMS Determination Of Diagnostic Lab Test Payments Required Under HR 2768
This article was originally published in The Gray Sheet
Executive Summary
The Centers for Medicare & Medicaid Services would be directed to develop procedures for determining a basis and payment amounts for clinical diagnostic laboratory tests under an amendment to the "Medicare Regulatory and Contracting Relief Act" (HR 2768) adopted by the House Ways & Means Committee during an Oct. 11 mark-up.
You may also be interested in...
IVD National Fee Schedule, MDUFMA Oversight Among AdvaMed 2003 Goals
Securing adequate Medicare payment for in vitro diagnostics is one of several legislative priorities for AdvaMed in 2003
IVD National Fee Schedule, MDUFMA Oversight Among AdvaMed 2003 Goals
Securing adequate Medicare payment for in vitro diagnostics is one of several legislative priorities for AdvaMed in 2003
Device Inpatient Payment, Medicare Contractor Reforms Pass With Drug Bill
The Senate will take up Medicare contractor and inpatient prospective payment reform proposals within the "Medicare Modernization and Prescription Drug Act" of 2002 (HR 4954) after the July 4 recess